CLINICAL, LABORATORY AND X-RAY PECULIARITIES OF INVASIVE ASPERGILLOSIS IN B-CELLULAR LYMPHOMS PATIENTS

CLINICAL, LABORATORY AND X-RAY PECULIARITIES OF INVASIVE ASPERGILLOSIS IN B-CELLULAR LYMPHOMS PATIENTS

The study included 108 patients with B-cell lymphoma which had complication with invasive aspergillosis, 57 patients with Hodgkin lymphoma (HL) and 51 patients with non-Hodgkin lymphoma (NHL). All patients in both groups received chemotherapy before the development of invasive aspergillosis, 73% of...

Full description

Bibliographic Details
Main Authors:	Y. A. CHUDINOVSKIKH, T. Y. SEMIGLAZOVA, N. N. KLIMKO, A. A. BARCHUK, O. V. SHADRIVOVA, E. V. FROLOVA, T. S. BOGOMOLOVA, S. M. IGNATIEVA, S. M. ALEXEEV, I. S. ZYUZGIN, L. V. FILATOVA, V. V. SEMIGLAZOV, E. V. KHARCHENKO, A. B. KOSICHKINA, M. S. MOTALKINA, U. B. KHADONOV, Y. A. OLEYNIK, A. A. ZVERKOVA, I. V. OSHMATOVA, A. Y. SUBORA, S. A. SHALAEV, P. S. SHILO
Format:	Article
Language:	Russian
Published:	Remedium Group LLC 2017-06-01
Series:	Медицинский совет
Subjects:	invasive aspergillosis b-cell lymphoma aspergillus spp
Online Access:	https://www.med-sovet.pro/jour/article/view/1899

Similar Items

DIFFERENTIAL DIAGNOSIS OF LYMPHOMAS OF THE MEDIASTINUM: A VIEW OF THE ONCOLOGIST AND PATHOLOGIST
by: E. V. KHARCHENKO, et al.
Published: (2017-06-01)

P1384: EFFECT OF NUTRITIONAL SUPPORT ON THE INCIDENCE OF MUCOSITIS IN AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION (AUTOHSCT) IN PATIENTS WITH HODGKIN’S LYMPHOMA. (INTERIM RESULTS)
by: S. Volchenkov, et al.
Published: (2022-06-01)

P1350: THE EFFICACY OF UPFRONT HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN DECREASING RELAPSE RATE IN IV STAGE AND HIGH-INTERMEDIATE/HIGH IPI RISK GROUPS DLBCL
by: A. Koviazin, et al.
Published: (2022-06-01)

Short- and long-term outcomes from the upfront high-dose chemotherapy, followed by autologous hematopoietic stem cell transplantation in diffuse large B-cell lymphoma
by: A. K. Koviazin, et al.
Published: (2022-06-01)

Prognostic impact of immunohistochemical and molecular genetic markers in Diffuse Large B-cell lymphoma
by: E. V. Kharchenko, et al.
Published: (2019-12-01)

The illustration of the successful mobilization of hematopoietic stem cells using plerixafor and pegfilgrastim in the patient with non-hodgkin's lymphoma
by: M S Motalkina, et al.
Published: (2015-06-01)

Problems of diagnostics and treatment of breast phyllodes tumors
by: Van Shu, et al.
Published: (2016-12-01)

efficacy of local hyperthermia in chemotherapy and /or radiation therapy for recurrences of hodgkin’s lymphom
by: O. K. Kurpeshev, et al.
Published: (2016-02-01)

INVASIVE ASPERGILLOSIS AND MUCORMYCOSIS IN ONCOHEMATOLOGICAL PATIENTS
by: O. V. Shadrivova, et al.
Published: (2018-07-01)

Breakthrough invasive candidiasis in pediatric patient with Ewing’s sarcoma: dinical case report and literature review
by: Yu. V. Dinikina, et al.
Published: (2019-12-01)

P1316: INCREASED EFFICACY OF INTERMEDIATE-DOSE ARAC+G-CSF COMPARED TO CY+G-CSF AND PLERIXAFOR+G-CSF AS A STEM CELL MOBILIZATION REGIMEN IN POOR MOBILIZERS WITH HEMATOLOGICAL MALIGNANCIES
by: Svetlana Elkhova, et al.
Published: (2023-08-01)

Invasive aspergillosis: results of multicenter study
by: N. N. Klimko, et al.
Published: (2014-09-01)

Invasive aspergillosis: results of multicenter study
by: N. N. Klimko, et al.
Published: (2014-09-01)

ORGANIZATIONAL AND ECONOMIC MECHANISM FOR INTRODUCTION OF ARTIFICIAL INTELLIGENCE TECHNOLOGIES IN RUSSIA
by: A. V. Alexeev
Published: (2020-11-01)

Quality of life is the fundamental criterion of the efficacy of targeted therapy in patients with metastatic Her2-positive breast cancer
by: T Yu Semiglazova, et al.
Published: (2015-03-01)

CXCL10 GENE PROMOTER POLYMORPHISM A-1447G MODULATES PROTEIN EXPRESSION IN SERUM AND ASSOCIATED WITH INVASIVE ASPERGILLOSIS IN FEMALE ONCOHEMATOLOGICAL PATIENTS
by: A. E. Taraskina, et al.
Published: (2018-12-01)

The role of gut microbiota in forming a response to immunotherapy of malignant neoplasms: problem state
by: T. Yu. Semiglazova, et al.
Published: (2018-07-01)

Problems of diagnostics and treatment of the epithelial and non-epithelial breast tumors
by: Van Shu, et al.
Published: (2017-05-01)

General St. Gallen-2015 guidelines for the treatment of early breast cancer (adapted by the experts of the Russian Society of Breast Oncologists)
by: V. F. Semiglazov, et al.
Published: (2015-09-01)

Invasive pulmonary aspergillosisas a complication of severe influenza (case report)
by: Yu. E. Melekhina, et al.
Published: (2020-03-01)

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy
by: E. A. Bus’ko, et al.
Published: (2017-02-01)

PERORAL FORMS OF CYTOSTATIC DRUGS IN THERAPY OF METASTATIC MAMMARY GLAND CANCER: ROLE IN CLINICAL PRACTICE
by: G. M. TELETAEVA, et al.
Published: (2016-12-01)

NEW ADVANCES IN THE TREATMENT OF BREAST CANCER: THE ROLE EPOTHILONES
by: T. Y. SEMIGLAZOVA, et al.
Published: (2017-06-01)

Invasive aspergillosis a complication severe respiratory viral infections (influenza and COVID-19)
by: N. N. Klimko, et al.
Published: (2021-12-01)

MOLECULAR GENETIC AND IMMUNOLOGICAL ASPECTS OF INVASIVE ASPERGILLOSIS
by: O. V. Shadrivova, et al.
Published: (2017-04-01)

Features of nutritional support during stem cell transplantation
by: S. A. Volchenkov, et al.
Published: (2020-07-01)

Invasive aspergillosis in children and adolescents with solid tumors: clinical cases and registry analysis
by: Yu. V. Dinikina, et al.
Published: (2019-04-01)

Pulmonary Aspergillosis in Patients with Cystic Fibrosis in Russian Federation
by: Ya. I. Kozlova, et al.
Published: (2018-07-01)

Comparative characteristics of methods of assessing the level of social and economic development of a regional social and economic system
by: A. V. Alexeev, et al.
Published: (2018-06-01)

Localisation cutanée du lymphome de Manteau
by: Naoufal Hjira, et al.
Published: (2013-11-01)

ADJUVANT HORMONE THERAPY ELIGIBILITY OF PREMENOPAUSAL WOMEN WITH ER+ BREAST CANCER
by: V. F. SEMIGLAZOV, et al.
Published: (2017-06-01)

International rehabilitation model for oncological patients
by: T. Yu. Semiglazova, et al.
Published: (2018-07-01)

New opportunities to improve of duration and quality of life: eribulin in the treatment of patients with advanced breast cancer
by: T Yu Semiglazova, et al.
Published: (2016-06-01)

Quality of life is an important criterion for the efficiency of targeted therapy for metastatic skeletal involvement in breast cancer
by: T. Yu. Semiglazova, et al.
Published: (2014-07-01)

Interferon-regulating activity of the CelAgrip drug and its influence on the formation of reactive oxygen species and expression of innate immunity genes in Burkitt’s lymphome cell cultures
by: Alexander N. Narovlyansky, et al.
Published: (2020-05-01)

Neoadjuvant treatment for breast cancer
by: V. F. Semiglazov, et al.
Published: (2014-07-01)

Current approaches to the treatment of HER2‑positive breast cancer with brain metastases
by: T. Yu. Semiglazova, et al.
Published: (2021-06-01)

State of immune status in hematological patients with invasive aspergillosis
by: E. V. Frolova, et al.
Published: (2014-09-01)

Breast cancer biomarker (ER, PR, HER2) changes in the phenotype after neoadjuvant treatment
by: V. O. Bashlyk, et al.
Published: (2018-07-01)

NEOADJUVANT ENDOCRINE THERAPY FOR PATIENTS WITH ESTROGEN-RECEPTOR-POSITIVE BREAST CANCER
by: V. F. Semiglazov, et al.
Published: (2018-07-01)